ReviewFrontiers in pharmacology2022

JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies.

Bilal Rah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.